229 related articles for article (PubMed ID: 31476153)
1. Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging.
Charil A; Shcherbinin S; Southekal S; Devous MD; Mintun M; Murray ME; Miller BB; Schwarz AJ
J Alzheimers Dis; 2019; 71(3):1037-1048. PubMed ID: 31476153
[TBL] [Abstract][Full Text] [Related]
2. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
3. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
[TBL] [Abstract][Full Text] [Related]
4. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.
Fleisher AS; Pontecorvo MJ; Devous MD; Lu M; Arora AK; Truocchio SP; Aldea P; Flitter M; Locascio T; Devine M; Siderowf A; Beach TG; Montine TJ; Serrano GE; Curtis C; Perrin A; Salloway S; Daniel M; Wellman C; Joshi AD; Irwin DJ; Lowe VJ; Seeley WW; Ikonomovic MD; Masdeu JC; Kennedy I; Harris T; Navitsky M; Southekal S; Mintun MA;
JAMA Neurol; 2020 Jul; 77(7):829-839. PubMed ID: 32338734
[TBL] [Abstract][Full Text] [Related]
5. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
[TBL] [Abstract][Full Text] [Related]
7. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
8. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
[TBL] [Abstract][Full Text] [Related]
10. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
11. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review.
Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E
Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963
[TBL] [Abstract][Full Text] [Related]
12. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
Ossenkoppele R; Lyoo CH; Sudre CH; van Westen D; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Westman E; Tsai R; Kramer J; Boxer AL; Gorno-Tempini ML; La Joie R; Miller BL; Rabinovici GD; Hansson O
Alzheimers Dement; 2020 Feb; 16(2):335-344. PubMed ID: 31672482
[TBL] [Abstract][Full Text] [Related]
13. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
14. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
Ossenkoppele R; Rabinovici GD; Smith R; Cho H; Schöll M; Strandberg O; Palmqvist S; Mattsson N; Janelidze S; Santillo A; Ohlsson T; Jögi J; Tsai R; La Joie R; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; Choi JY; Ryu YH; Lyoo CH; Hansson O
JAMA; 2018 Sep; 320(11):1151-1162. PubMed ID: 30326496
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal [
Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
[TBL] [Abstract][Full Text] [Related]
17. Compensating for choroid plexus based off-target signal in the hippocampus using
Pawlik D; Leuzy A; Strandberg O; Smith R
Neuroimage; 2020 Nov; 221():117193. PubMed ID: 32711062
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
Ghirelli A; Tosakulwong N; Weigand SD; Clark HM; Ali F; Botha H; Duffy JR; Utianski RL; Buciuc M; Murray ME; Labuzan SA; Spychalla AJ; Pham NTT; Schwarz CG; Senjem ML; Machulda MM; Baker M; Rademakers R; Filippi M; Jack CR; Lowe VJ; Parisi JE; Dickson DW; Josephs KA; Whitwell JL
Ann Neurol; 2020 Nov; 88(5):1009-1022. PubMed ID: 32869362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]